Braden Michael Leonard is of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 141,800 shares of ADVM, which is worth approximately $714,672. The most recent transaction as insider was on Mar 27, 2025, when has been sold 16,593 shares (Common Stock) at a price of $5.19 per share, resulting in proceeds of $86,117. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K
n/a 3M change
n/a 12M change
Total Value Held $714,672

Braden Michael Leonard Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 27 2025
SELL
Open market or private purchase
$86,117 $5.19 p/Share
16,593 Reduced 10.48%
141,800 Common Stock
Mar 26 2025
BUY
Open market or private purchase
$102,851 $5.04 p/Share
20,407 Added 14.01%
125,207 Common Stock

Also insider at

GMTX
Gemini Therapeutics, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
RVP
RETRACTABLE TECHNOLOGIES INC Healthcare
ASTC
ASTROTECH Corp Industrials
MTCR
Metacrine, Inc. Healthcare
STSA
Satsuma Pharmaceuticals, Inc. Healthcare
CYT
Cyteir Therapeutics, Inc. Healthcare
AVRO
AVROBIO, Inc. Healthcare
RPHM
Reneo Pharmaceuticals, Inc. Healthcare
ACRS
Aclaris Therapeutics, Inc. Healthcare
ANTX
AN2 Therapeutics, Inc. Healthcare
TLIS
Talis Biomedical Corp Healthcare
BML

Braden Michael Leonard

Zionsville, IN

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM